Synopsys, Inc. $SNPS Shares Bought by Fulcrum Asset Management LLP

Fulcrum Asset Management LLP lifted its stake in Synopsys, Inc. (NASDAQ:SNPS) by 55.8% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 8,705 shares of the semiconductor company’s stock after acquiring an additional 3,118 shares during the period. Fulcrum Asset Management LLP’s holdings in Synopsys were worth $3,613,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also made changes to their positions in the company. Elevation Wealth Partners LLC increased its stake in shares of Synopsys by 96.4% during the second quarter. Elevation Wealth Partners LLC now owns 55 shares of the semiconductor company’s stock valued at $25,000 after acquiring an additional 27 shares during the period. Osbon Capital Management LLC acquired a new stake in Synopsys in the second quarter worth approximately $25,000. IMG Wealth Management Inc. acquired a new stake in Synopsys in the second quarter worth approximately $28,000. GK Wealth Management LLC bought a new position in Synopsys during the 3rd quarter valued at $28,000. Finally, Geneos Wealth Management Inc. boosted its stake in Synopsys by 151.5% during the 1st quarter. Geneos Wealth Management Inc. now owns 83 shares of the semiconductor company’s stock valued at $33,000 after purchasing an additional 50 shares in the last quarter. 85.47% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Several equities analysts have recently issued reports on the company. UBS Group set a $570.00 price target on Synopsys in a research report on Thursday, August 27th. HSBC lowered Synopsys from a “buy” rating to a “reduce” rating in a report on Friday, September 25th. Morgan Stanley raised their target price on Synopsys from $500.00 to $574.00 and gave the company an “overweight” rating in a research note on Tuesday, October 20th. Roth Capital raised Synopsys to a “buy” rating in a research note on Friday, September 25th. Finally, Barclays started coverage on Synopsys in a report on Friday, September 25th. They set an “overweight” rating on the stock. One research analyst has rated the stock with a Strong Buy rating, twenty-two have issued a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $575.00.

Synopsys Trading Up 3.7%

Shares of SNPS opened at $466.97 on Tuesday. The business’s 50-day moving average price is $442.10 and its 200 day moving average price is $442.00. The company has a current ratio of 1.34, a quick ratio of 1.24 and a debt-to-equity ratio of 0.29. The stock has a market capitalization of $89.49 billion, a P/E ratio of 47.05, a P/E/G ratio of 1.47 and a beta of 1.18. Synopsys, Inc. has a 1-year low of $362.55 and a 1-year high of $539.48.

Synopsys (NASDAQ:SNPS) last posted its quarterly earnings data on Wednesday, August 26th. The semiconductor company reported $3.91 EPS for the quarter, beating analysts’ consensus estimates of $3.67 by $0.24. Synopsys had a net margin of 11.43% and a return on equity of 6.24%. The company had revenue of $2.48 billion during the quarter, compared to analyst estimates of $2.44 billion. During the same period in the prior year, the firm earned $3.39 earnings per share. The business’s quarterly revenue was up 42.4% on a year-over-year basis. Synopsys has set its Q4 2026 guidance at 4.100-4.160 EPS and its FY 2026 guidance at 15.040-15.100 EPS. Analysts expect that Synopsys, Inc. will post 11.01 earnings per share for the current year.

Synopsys announced that its Board of Directors has approved a stock buyback program on Monday, October 5th that allows the company to repurchase $1 billion in outstanding shares. This repurchase authorization allows the semiconductor company to buy up to 1.1% of its shares through open market purchases. Share repurchase programs are typically an indication that the company’s board of directors believes its stock is undervalued.

Insider Activity

In other news, CEO Sassine Ghazi sold 14,604 shares of the business’s stock in a transaction that occurred on Thursday, October 15th. The shares were sold at an average price of $462.84, for a total transaction of $6,759,315.36. Following the sale, the chief executive officer owned 76,865 shares in the company, valued at $35,576,196.60. The trade was a 15.97% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO Sudhindra Kankanwadi sold 9,170 shares of the company’s stock in a transaction that occurred on Tuesday, October 6th. The shares were sold at an average price of $500.00, for a total transaction of $4,585,000.00. Following the completion of the sale, the chief financial officer owned 22,717 shares of the company’s stock, valued at approximately $11,358,500. This trade represents a 28.76% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold 117,163 shares of company stock worth $51,366,457 over the last three months. 0.56% of the stock is owned by insiders.

Synopsys Profile

Synopsys, Inc develops software, semiconductor intellectual property (IP) and services used to design and verify electronic systems. Its electronic design automation (EDA) tools help customers create, simulate, test and validate chips and other complex electronic products, while its IP portfolio provides reusable building blocks for semiconductor designs.

The company also offers software security and quality tools that help developers identify vulnerabilities and assess applications throughout the software development process.